9 articles filed here
A preprint posted last week shows single-cell foundation models transfer across a billion years of evolution. The peer-reviewed benchmark record is far less flattering. Here is what the evidence actually supports.
Synthetic biology is handing the design of medicine-making microbes to machine learning. We look at what AI-guided strain engineering has actually delivered, where it still stalls, and what the evidence supports.
The first blinded, wet-lab-validated benchmark for AI antibody design just landed in Nature Biotechnology. Here is what the models got right, and wrong.
Genentech validated the first AI-discovered neuroscience drug target from its $12B Recursion partnership. A proof point the AI-drug discovery field needed.
Jennifer Doudna's lab used an AI protein-design model to build a synthetic gene-editing enzyme, SynTnpB, that edits human cells nearly twice as efficiently as the natural version. Here is what the Science paper actually shows, and what it does not.
